GSK provides further update on phase III RSV maternal vaccine candidate programme
Provider: View Press Release Type: Link Title: GSK provides further update on phase III RSV maternal vaccine candidate programme | GSK Description: Further to the voluntary pause shared on February 18, the Company has decided to stop enrolment and vaccination in trials
Medicago and GSK announce the approval by Health Canada of COVIFENZ®, an adjuvanted plant-based COVID-19 vaccine
Provider: View Press Release Type: Link Title: Medicago and GSK announce the approval by Health Canada of COVIFENZ®, an adjuvanted plant-based COVID-19 vaccine | GSK Description: A vaccine manufactured in plants and developed in Canada
GSK announces independent Consumer Healthcare company is to be called Haleon
Provider: View Press Release Type: Link Title: GSK announces independent Consumer Healthcare company is to be called Haleon | GSK Description: Haleon will be a new world-leader in consumer health with an exceptional portfolio of category-leading brands.
China’s National Medical Products Administration approves Benlysta (belimumab) for adult patients with active lupus nephritis
Provider: View Press Release Type: Link Title: China’s National Medical Products Administration approves Benlysta (belimumab) for adult patients with active lupus nephritis | GSK Description: First and only biologic approved in China for both systemic lupus erythematosus and lupus nephritis
